<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(4)</volume><submitter>Nakano D</submitter><pubmed_abstract>(a) Summary for SGLT2i-induced alterations in 48 chemokines/cytokines in Hep3B and Huh7 cells. (b) SGLT2i-induced changes in the medium CXCL1 level (each &lt;i>n&lt;/i> = 4). (c) SGLT2i-induced changes in the medium CXCL8 level (each &lt;i>n&lt;/i> = 4). (d) SGLT2i-induced changes in the medium CXCL10 level (each &lt;i>n&lt;/i> = 4), (e) SGLT2i-induced changes in the medium M-CSF level (each &lt;i>n&lt;/i> = 4). The SGLT2i-induced significant changes in chemokines/cytokines are expressed as the percentage of control (the mean value of the control was set as 100%). CXCL, C-X-C motif chemokine ligand; G-CSF, granulocyte colony-stimulating factor; IL, interleukin; LIF, leukemia inhibitory factor; M-CSF, macrophage colony-stimulating factor; MIP-1α, macrophage inflammatory protein-1α; SDF-1α, stromal-cell-derived fac</pubmed_abstract><journal>JGH open : an open access journal of gastroenterology and hepatology</journal><pagination>270-273</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9021706</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effects of SGLT2 inhibitor on tumor-releasing chemokines/cytokines in Hep3B and Huh7 cells.</pubmed_title><pmcid>PMC9021706</pmcid><pubmed_authors>Yoshio S</pubmed_authors><pubmed_authors>Koga H</pubmed_authors><pubmed_authors>Torimura T</pubmed_authors><pubmed_authors>Tsutsumi T</pubmed_authors><pubmed_authors>Nakano D</pubmed_authors><pubmed_authors>Kawaguchi T</pubmed_authors><pubmed_authors>Hayakawa M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effects of SGLT2 inhibitor on tumor-releasing chemokines/cytokines in Hep3B and Huh7 cells.</name><description>(a) Summary for SGLT2i-induced alterations in 48 chemokines/cytokines in Hep3B and Huh7 cells. (b) SGLT2i-induced changes in the medium CXCL1 level (each &lt;i>n&lt;/i> = 4). (c) SGLT2i-induced changes in the medium CXCL8 level (each &lt;i>n&lt;/i> = 4). (d) SGLT2i-induced changes in the medium CXCL10 level (each &lt;i>n&lt;/i> = 4), (e) SGLT2i-induced changes in the medium M-CSF level (each &lt;i>n&lt;/i> = 4). The SGLT2i-induced significant changes in chemokines/cytokines are expressed as the percentage of control (the mean value of the control was set as 100%). CXCL, C-X-C motif chemokine ligand; G-CSF, granulocyte colony-stimulating factor; IL, interleukin; LIF, leukemia inhibitory factor; M-CSF, macrophage colony-stimulating factor; MIP-1α, macrophage inflammatory protein-1α; SDF-1α, stromal-cell-derived fac</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-04T19:09:46.998Z</modification><creation>2025-04-04T19:09:46.998Z</creation></dates><accession>S-EPMC9021706</accession><cross_references><pubmed>35475201</pubmed><doi>10.1002/jgh3.12730</doi></cross_references></HashMap>